Difference between revisions of "IOC61"
From Bioblast
Line 74: | Line 74: | ||
* [[Alexeyev M|'''Alexeyev Mikhail, USA''']]: Mouse modeling of mitochondrial disorders caused by mtDNA mutations. | * [[Alexeyev M|'''Alexeyev Mikhail, USA''']]: Mouse modeling of mitochondrial disorders caused by mtDNA mutations. | ||
* [[Angelin A|'''Angelin Alessia''']]: Function in muscle tissue; in particular human muscle disorder (muscular dystrophy). | * [[Angelin A|'''Angelin Alessia, USA''']]: Function in muscle tissue; in particular human muscle disorder (muscular dystrophy). | ||
* [[Balboa Castillo E|'''Balboa Castillo Elisa, Chile''']]: Increase in mitochondrial cholesterol and dysfunction in NPC. | * [[Balboa Castillo E|'''Balboa Castillo Elisa, Chile''']]: Increase in mitochondrial cholesterol and dysfunction in NPC. | ||
* [[Castelein N|'''Castelein Natascha, Belgium''']]: The role of mitochondria in dietary restriction induced lifespan extension in ''C. elegan''s. | * [[Castelein N|'''Castelein Natascha, Belgium''']]: The role of mitochondria in dietary restriction induced lifespan extension in ''C. elegan''s. | ||
* [[Gabrielova E|'''Gabrielova Eva, Czech Republic''']]: [[Gabrielova IOC61|Evaluation of oxygen consumption in rat heart mitochondria treatment by polyphenol compounds.]] | * [[Gabrielova E|'''Gabrielova Eva, Czech Republic''']]: [[Gabrielova IOC61|Evaluation of oxygen consumption in rat heart mitochondria treatment by polyphenol compounds.]] | ||
* [[Hals I|'''Hals Ingrid, Norway''']]: Effects of hypoxia in pancreatic beta-cells on mitochondrial functions. | * [[Hals I|'''Hals Ingrid, Norway''']]: Effects of hypoxia in pancreatic beta-cells on mitochondrial functions. | ||
* [[Hancock S|'''Hancock Saege''']] | * [[Hancock S|'''Hancock Saege, USA''']] | ||
* [[Kasal D|'''Kasal Daniel, Brazil''']]: Modulation of cardiomyocyte respiration by bone marrow stem cells. | * [[Kasal D|'''Kasal Daniel, Brazil''']]: Modulation of cardiomyocyte respiration by bone marrow stem cells. | ||
* [[Labieniec M|'''Labieniec Magdalena, Poland''']]: Mitocondrial respiratory capacity; mt membrane potential; calcium homeostasis; mitochondria in health and pathology (diabetes, neurodegenerative diseases, cancer); mt function; ROS | * [[Labieniec M|'''Labieniec Magdalena, Poland''']]: Mitocondrial respiratory capacity; mt membrane potential; calcium homeostasis; mitochondria in health and pathology (diabetes, neurodegenerative diseases, cancer); mt function; ROS | ||
Line 88: | Line 88: | ||
* [[Nuskova H|'''Nuskova Hana, Czech Republic''']]: Mitochondrial Energetics in Health and Disease. | * [[Nuskova H|'''Nuskova Hana, Czech Republic''']]: Mitochondrial Energetics in Health and Disease. | ||
* [[Sanz A|'''Sanz Alberto, Finland''']]: Mechanism causing aging and the role of mitochondria in this process. | * [[Sanz A|'''Sanz Alberto, Finland''']]: Mechanism causing aging and the role of mitochondria in this process. | ||
* [[Scherer Alves L|'''Scherer Alves Leonardo''']]: Mitochondrial Physiology as a force of human adaptation and evolution to differnet geograpie niches and the relation between the environment and mitochondrial genes in human common diseases. | * [[Scherer Alves L|'''Scherer Alves Leonardo, USA''']]: Mitochondrial Physiology as a force of human adaptation and evolution to differnet geograpie niches and the relation between the environment and mitochondrial genes in human common diseases. | ||
* [[Watala C|'''Watala Cezary, Poland''']]: Mitocondrial respiratory capacity; mt membrane potential; calcium homeostasis; mitochondria in health and pathology (diabetes, neurodegenerative diseases, cancer); mt function; ROS | * [[Watala C|'''Watala Cezary, Poland''']]: Mitocondrial respiratory capacity; mt membrane potential; calcium homeostasis; mitochondria in health and pathology (diabetes, neurodegenerative diseases, cancer); mt function; ROS | ||
* [[Yokota T|'''Yokota Takashi, Denmark''']]: The role of mitochondria in chronic heart failure, diabetes, or obesity. | * [[Yokota T|'''Yokota Takashi, Denmark''']]: The role of mitochondria in chronic heart failure, diabetes, or obesity. |
Revision as of 10:49, 28 March 2011
O2k-Workshop on High-Resolution Respirometry - Introductory and Advanced
Schröcken, Vorarlberg, Austria 26 April - 1 May, 2011.
Hotel Körbersee
For some pictures, see IOC60
More information on IOC61: http://www.oroboros.at/index.php?nextcourse
Contact: Katrin Stecher, administration; Email [email protected]
Course structure
- Introductory and advanced groups will be working in parallel session, to adjust the programme optimally to the specific needs of the participants in different workpackages.
- Hot Topics in Mitochondrial Physiology: 10+5 min
Abstracts
For the abstract format, see Author_IOC61.
Combined introductory and advanced O2k-Workshop with parallel sessions
- A: Introductory lectures and hands-on experiments for basic HRR in small working teams:
A1. General HRR topics
- O2k-assembly,
- Polarographic oxygen sensor (OroboPOS) service,
- POS calibration,
- DatLab software: principles and operation,
- Titration-Injection-microPump - TIP2k.
A2. Protocols in HRR
- Introduction to fundamental elements of mitochondrial respiratory physiology,
- Design and examples of experimental protocols with intact cells, permeabilized cells and tissues, isolated mitochondria.
A3. Hands-on experiments with the O2k
- Measurement of instrumental background oxygen flux, manual and TIP2k-feedback control,
- Intact cells: Respirometric reference assay with yeast, phosphorylation control protocol,
- Preparation of permeabilized muscle fibres,
- HRR with permeabilized muscle fibres.
A4. Presentation and interpretation of oxygen flux
- Normalization of respiration per tissue or per mitochondrial marker,
- Coupling control ratios,
- Substrate control ratios,
- Generalized flux control ratios.
A5. Overview on O2k-MultiSensor applications - Simultaneous measurement of respiration and:
- Mitochondrial membrane potential (TPP+ electrode),
- Acidification (pH electrode),
- Nitric oxide (amperometric),
- Spectrophotometry (cytochrome spectra),
- Spectrofluorimetry (Amplex red, safranin, etc.)
- B: Advanced users will join in small working teams in parallel sessions, with specific topics:
B1. O2k-MultiSensor and TIP2k
- Hands-on MultiSensor TPP+ applications, see TPP special interest group during an International Oxygraph Course
- Oxygen kinetics: experimental examples with TIP2k-feedback control (oxystat) and data analysis,
- ADP kinetics: experimental examples with TIP2-steady state control and data analysis,
- pH-stat feedback control,
B2. Theoretical perspectives
- Advanced experimental protocols,
- Quality control - towards quality assurance;
- Add your topic:
Participants and areas of interest
- Alexeyev Mikhail, USA: Mouse modeling of mitochondrial disorders caused by mtDNA mutations.
- Angelin Alessia, USA: Function in muscle tissue; in particular human muscle disorder (muscular dystrophy).
- Balboa Castillo Elisa, Chile: Increase in mitochondrial cholesterol and dysfunction in NPC.
- Castelein Natascha, Belgium: The role of mitochondria in dietary restriction induced lifespan extension in C. elegans.
- Gabrielova Eva, Czech Republic: Evaluation of oxygen consumption in rat heart mitochondria treatment by polyphenol compounds.
- Hals Ingrid, Norway: Effects of hypoxia in pancreatic beta-cells on mitochondrial functions.
- Hancock Saege, USA
- Kasal Daniel, Brazil: Modulation of cardiomyocyte respiration by bone marrow stem cells.
- Labieniec Magdalena, Poland: Mitocondrial respiratory capacity; mt membrane potential; calcium homeostasis; mitochondria in health and pathology (diabetes, neurodegenerative diseases, cancer); mt function; ROS
- Magnifico Maria Chiara, Italy: Measurement of oxygen consumption, respiratory flux and membrane potential in HaCaT cells.
- Manjeri Ganesh, The Netherlands: Understanding oxygen flux in mitochondrial disorders working with skin fibroblasts.
- Marelsson Sigurdur, Sweden: The role of mitochondrial dysfunction in encephalopaty.
- Morein Torbjörn, Sweden
- Nuskova Hana, Czech Republic: Mitochondrial Energetics in Health and Disease.
- Sanz Alberto, Finland: Mechanism causing aging and the role of mitochondria in this process.
- Scherer Alves Leonardo, USA: Mitochondrial Physiology as a force of human adaptation and evolution to differnet geograpie niches and the relation between the environment and mitochondrial genes in human common diseases.
- Watala Cezary, Poland: Mitocondrial respiratory capacity; mt membrane potential; calcium homeostasis; mitochondria in health and pathology (diabetes, neurodegenerative diseases, cancer); mt function; ROS
- Yokota Takashi, Denmark: The role of mitochondria in chronic heart failure, diabetes, or obesity.
Tutors
- Erich Gnaiger (Innsbruck Medical University, AT; OROBOROS INSTRUMENTS, AT)
- Mario Fasching (OROBOROS INSTRUMENTS, AT)
- Dominik Pesta (Innsbruck Medical University, AT)
- Zuzana Sumbalova (OROBOROS INSTRUMENTS, AT)